Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • RockChalkJayhawk
    Senior Member
    • Mar 2009
    • 192

    #1

    Cuffdiff multi-protein vs multi-promoter

    I was hoping someone could clarify. I don't quite understnd the difference between the x_y_tss and x_y_CDS. I know it has something to do with the tss_ID and p_IDs, and I've read the manual 10 times. Does the x_y_tss tests mean that transcripts from the same gene, but at same promoter site are expressed differently and the x_y_CDS mean alternative transcripts but same promoter? In other words tss is for exon skipping and CDS is for alternative promoters?

    If this is the case, what is the difference in these differential expression tests from the cds.diff, splicing.diff, and promoters.diff files?
  • Cole Trapnell
    Senior Member
    • Nov 2008
    • 213

    #2
    We'll clarify the manual with a picture, which I think will explain this issue much better. In the short term: suppose you have a gene with two isoforms, each of which starts at a different TSS. They could actually code for the same protein (i.e. only differ in UTR length), or they could code for different proteins. In the first case, they would have the same p_id. In the second case, they'd have different p_ids. The reason we did it this way is that we are interested in cases where you have switching in promoter use, and we wanted to see in how many of these genes that switch might actually mean a switch in the dominant protein being produced.

    In our manual and terminology, "splicing" refers only to the processing of a primary transcript, so alternative TSS doesn't strictly fall under "splicing". I realize that many people group alternative TSS under "alternative splicing".

    So within a given gene:

    X_Y_tss_group_exp has rows that are groups of transcripts that share a tss_id, and gives the total FPKM for each TSS group
    X_Y_gene_exp has rows that are groups of transcripts that share a gene_id, and gives the total FPKM for each gene
    X_Y_cds_exp has rows that are groups of transcripts that share a p_id, and gives the total FPKM for each CDS group

    X_Y_splicing has rows that are groups of transcripts that share a tss_id, and gives the change in relative abundance of transcripts that share a tss_id

    X_Y_promoters has rows that are groups of primary transcripts that share a gene_id. There is one primary transcript for each tss_id, and its expression is given in X_Y_tss_group_exp. X_Y_promoters gives the change in relative abundance of primary transcripts that share a gene_id, i.e. genes with promoter switching.

    X_Y_cds (not X_Y_cds_exp) is just like X_Y_promoters, except instead of primary transcripts (transcripts grouped by tss_id), we're working with groups of transcripts that code for the same protein (transcripts grouped by tss_id).
    Last edited by Cole Trapnell; 03-26-2010, 09:18 AM.

    Comment

    • RockChalkJayhawk
      Senior Member
      • Mar 2009
      • 192

      #3
      Originally posted by Cole Trapnell View Post
      We'll clarify the manual with a picture, which I think will explain this issue much better. In the short term: suppose you have a gene with two isoforms, each of which starts at a different TSS. They could actually code for the same protein (i.e. only differ in UTR length), or they could code for different proteins. In the first case, they would have the same p_id. In the second case, they'd have different p_ids. The reason we did it this way is that we are interested in cases where you have switching in promoter use, and we wanted to see in how many of these genes that switch might actually mean a switch in the dominant protein being produced.
      So transcripts sharing p_id means they have alternative UTRs (but same protein sequence) whereas those that have different p_id are involved in exon skipping?

      I may just have to wait for the picture. How soon do you think the Cufflinks paper will be out?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 07:41 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...